Cochlearoids L (1) and M (2), two new meroterpenoids and three known ones, were isolated from the fruiting bodies of Ganoderma cochlear. The new structures were elucidated by spectroscopic and chemical methods. Biological evaluation showed that 1 could inhibit bromodomain-containing protein 4 (BRD4) with IC 50 value of 68.7 μM. Besides, 1 was found to have weak cytotoxic activities against three human cell lines (A549, K562, Huh-7) with IC 50 values in the range of 39.6-190.0 μM.
Bromodomain-containing protein 4 (BRD4) is implicated in many diseases such as cancer, acute myeloid leukemia, multiple myeloma, Burkitt's lymphoma [1, 2] . Small molecules that inhibit BRD4 have shown potential as antiinflammatory, antiviral, and anticancer agents [3] . Ganoderma species are a collection of mushrooms that are mainly found in the tropical regions [4] . Among these important species is Ganoderma lucidum (Chinese name lingzhi), used as famous traditional Chinese medicine for centuries, and has attracted great attention for decades [5, 6] . Previous chemical studies on this fungus revealed that it contains polysaccharides, triterpenoids, alkaloids, fatty acids, nucleotides, proteins, peptides, trace elements, sterols, and other natural hybrids [7] . Our group has reported structurally novel and biologically active meroterpenoids from G. lucidum or other Ganoderma species [8] [9] [10] [11] [12] [13] . To further explore meroterpenoids in Ganoderma, we have undertaken an investigation on G. cochlear and resulted in the isolation of cochlearines A and B, cochlearoids A−E [10] , and cochlearols A and B [13] , This inspired us to conduct an reinvestigation on this fungus, which led to the isolation of two new meroterpenoids, cochlearoids L (1) and M (2), and three known meroterpenoids. Biological tests of these isolates towards BRD4 and human cancer cells were subsequently conducted. to those of cochlearoid I [14] differing in that a hydroxymethylene in cochlearoid I is replaced by a methyl signal in the side chain. . These data are similar to those of cochlearoid J [14] . The only difference between 2 and cochlearoid J is that a hydroxymethylene in cochearoid J is replaced by a carbonyl signal in the side chain. This could be evidenced from the HMBC correlations of H-8′/C-9′ (δ C 133.7), C-10′ (δ C 171.9), and the observation of the chemical shift of C-15′ (δ C 16.3). Meanwhile, it was found that the chemical shift of H-8′ (δ H 5.47) in cochlearoid J is downshifted in 2 (δ H 6.01). As for the geometry of 2, the ROESY correlations of H-8′/H-11′ and H-12′/H-15′ indicate that the  8′(9′) and  13′(14′) double bonds are Z and E, respectively. As a consequence, the structure of 2, named cochlearoid M, was identified.
Three known analogues were identified as cochlearoids I (3) [14] , J (4) [14] , and H (5) [14] , respectively, by comparing their spectroscopic data with literature data. Of note, all these known meroterpenoids were previously isolated by our group in the previous investigation on G. cochlear.
As mentioned above, BRD4, a protein that is related to epigenetic regulation of gene expression via histone acetylation, is involved in modulation of a wide range of biological functions that are potentially relevant to the treatment of several disorders such as cancer. Therefore there is a great interest for developing BRD4 inhibitors. With this assay in hand, all the isolates were evaluated for their inhibitory effects on BRD4. It was found that only compound 1 exhibits inhibitory property with IC 50 value of 68.7 μM. Whereas the other compounds are inactive. In addition, cytotoxic assay shows that 1 exhibits potent inhibitory activity against A549, K562, and Huh-7 cell lines with IC 50 values of 39.6, 94.1, and 190.0 μM, respectively.
Experimental
General: UV spectra were recorded on a UV/VIS spectrophotometer. NMR spectra were recorded on a Bruker Avance 400MHz or a Bruker Avance III 600 MHz spectrometer, with TMS as an internal standard. ESIMS and HRESIMS were measured on an Agilent 6230 TOF MS spectrometer. C-18 silica gel (40-60 μm; Daiso Co., Japan), MCI gel CHP 20P (75-150 μm, Mitsubishi Chemical Industries, Tokyo, Japan), Sephadex LH-20 (Amersham Pharmacia, Uppsala, Sweden), and silica gel (200-300 mesh; Qingdao Marine Chemical Inc., People's Republic of China) were used for column chromatography. Preparative HPLC was carried out using an Agilent 1200 liquid chromatograph with a Thermo hypersil gold C18 column (250 mm × 21.2 mm, i.d., 5 μm). Semi-preparative HPLC was carried out using an Agilent 1200 liquid chromatograph with a YMC-Pack ODS-A column (250 mm ×10 mm,i.d., 5 μm). Cytotoxic activity was assessed using the CCK-8 method according to established procedures [15] . Cell lines, A549, Huh-7, K562 were purchased from Shanghai Cell Bank, Chinese Academy of Sciences. Cells were routinely grown and maintained in media RPMI 1640 or DMEM with 10% FBS and with 1% penicillin/streptomycin. All cell lines were incubated in a Thermo/Forma Scientific CO 2 Water Jacketed Incubator with 5% CO 2 in air at 37 • C. Cell viability assay was determined by the CCK-8 (DOjinDo, Japan) assay. Cells were seeded at a density of 400-800 cells/ well in 384 well microtiter plates and treated with various concentration of compounds or solvent control. After 72 h incubation, CCK-8 reagent was added, and absorbance was measured at 450 nm using Envision 2104 multi-label Reader (Perkin Elmer, USA). Dose response curves were plotted to determine the IC 50 values using Prism 5.0 (GraphPad Software Inc., USA). All of the experiments were performed in triplicate. IC 50 was determined for each compound from a plot of log (drug concentration) versus percentage of cells killed. The data reported with standard deviations are representative of at least three independent experiments. Taxol was used as the positive control with IC 50 values of 2.36, 20.73 and 2.79 nM on three cell lines (A549, Huh-7, K562), respectively.
Supplementary data: 1D, 2D NMR and HRESIMS spectra of the new compounds.
